Astorg has acquired Thermo Fisher Scientific Inc. for an undisclosed amount. This corporate acquisition sees Astorg taking ownership of the global leader in serving science, a company with approximately $40 billion in annual revenue. Thermo Fisher Scientific is widely recognized for its mission to enable customers to make the world healthier, cleaner, and safer, providing essential support across various scientific and healthcare domains.
Thermo Fisher Scientific's extensive operations span life sciences research, complex analytical challenges, laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Its global team delivers innovative technologies, purchasing convenience, and pharmaceutical services through a portfolio of industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
The acquisition by Astorg represents a strategic move to integrate a foundational player in the scientific and healthcare industries. For Astorg, this transaction secures a company with a robust market presence, diverse product and service offerings, and a critical role in global scientific advancement. The strategic rationale likely centers on leveraging Thermo Fisher Scientific's established leadership and comprehensive capabilities to drive continued growth and market penetration under new ownership.
Expected synergies from this acquisition are anticipated to build upon Thermo Fisher Scientific's existing strengths, potentially enhancing its capacity for innovation and expanding its global reach. The combined entity is positioned to continue supporting its broad customer base, from accelerating research to improving patient outcomes, maintaining its commitment to scientific progress and service excellence.